***The claim period is now open (see details below)***
A settlement agreement was reached to settle all class actions filed in Canada.
All persons residing in Canada who were prescribed and used Yasmin and/or YAZ between December 10, 2004 (for Yasmin) or January 6, 2009 (for YAZ) and November 30, 2011 (for residents of Ontario and Quebec), or October 4, 2016 (for residents of Canada other than Ontario and Quebec), and who were subsequently diagnosed with arterial thromboembolism, venous thromboembolism, and/or gallbladder disease, may submit a claim to try to obtain compensation under the settlement agreement.
Family members of a person meeting the above description may also submit a claim as a family member of that person, provided that the person has submitted a claim themselves.
For more information about the claims process, please visit the Claims Administrator’s website at: www.YasminYAZClassActionCanada.ca.
THE DEADLINE TO SUBMIT A CLAIM IS APRIL 9, 2027, AT 11:59 P.M. (EASTERN TIME).
Developments
Proceedings
In July 26, 2018, the Superior Court of Québec authorized the bringing of a class action against the defendant on behalf of all persons residing in Québec who were prescribed and ingested the oral contraceptives Yasmin and/or Yaz and who were diagnosed with deep vein thrombosis, pulmonary embolism, arterial thromboembolism or gallbladder disease, and their families. The Court’s decision is available here.
In November 15, 2018, the Québec Court of Appeal dismissed the application brought by the defendant for leave to appeal from the authorization order rendered by Justice Beaugé. Accordingly, the authorization order became final. The decision of the Court of Appeal is available here.
In February 15, 2019, following the authorization, an originating application was filed.
On August 19, 2021, judgment was rendered on a motion to strike the defendant's allegations and specifications. The Court’s decision is available here.
On September 2, 2021, the originating application was amended. This motion is available here.
Settlement agreement
On July 30, 2025, the parties to all the class actions across Canada signed a settlement agreement to put an end to the various disputes concerning the contraceptive pills Yasmin and YAZ and the alleged risks of venous thromboembolism, arterial thromboembolism, and gallbladder disease. The settlement agreement is available here.
This settlement provides for the payment of a lump sum of $9,050,000 by Bayer, Inc., without admission of liability. The settling class members will need to file a claim to obtain advantages from the sum. The advantages will be distributed according to a point system detailed in the Compensation and distribution protocol. The Compensation and distribution protocol is available here.
On November 14, 2025, the approval hearings for the Settlement Agreement and Class Counsel’s fees were held before the courts of Ontario and Québec. The Settlement Agreement and Class Counsel’s fees were approved by both courts, as reflected in the judgments issued on November 26 and 27, 2025. These judgments are available in our Documents section. Finally, on March 19, 2026, the Saskatchewan Court also approved the settlement agreement.
Claim process
The claims process for obtaining compensation under the approved Settlement Agreement commenced on October 15, 2026. Notices to Class Members were published through various media outlets to inform them of the approval of the Settlement Agreement and the opening of the claims period. Class Members who had registered with Class Counsel also received copies of these notices directly. Long-form and short-form notices can be viewed here.
Any person covered by the Settlement who wishes to participate must complete a Claim Form and submit it, together with all supporting documentation, to the Claims Administrator no later than April 9, 2027, at 11:59 p.m. (Eastern Time).
Please review the Class Member notices available in the Documents section for additional information regarding the claims process and the benefits available under the Settlement. Further information regarding the Settlement and the claims process is also available on the Claims Administrator’s website: www.YasminYAZClassActionCanada.ca
Epiq Class Action Services Canada Inc.
Attention: YAZ/Yasmin Class Action
P.O. Box 507 STN B
Ottawa, Ontario K1P 5P6
877-741-8728
[email protected]
If you do not submit a claim by April 9, 2027, at 11:59 p.m. (Eastern Time), you will not be eligible to receive compensation from the Settlement.
The claims process must be completed by each Settlement Class Member personally, unless that member has retained legal counsel to submit a claim on their behalf.
FAQs
Who Is Covered by the Yaz/Yasmin Class Action Settlement?
You may be affected by the Settlement Agreement, and the ongoing claims process if you are a resident of Canada who was prescribed and used Yasmin and/or YAZ between December 10, 2004 (for Yasmin) or January 6, 2009 (for YAZ) and November 30, 2011 (for residents of Ontario and Quebec), or October 4, 2016 (for residents of Canada other than Ontario and Quebec), and who was subsequently diagnosed with arterial thromboembolism, venous thromboembolism, and/or gallbladder disease.
Such individuals are considered eligible Class Members and may be eligible to participate in the claims process.
What should I do to protect my rights?
To protect your rights, you should:
- Obtain all pharmaceutical or medical records that prove the prescription and ingestion of Yasmin and/or Yaz ;
- Obtain all r medical records that prove the diagnosis of deep vein thrombosis, pulmonary embolism, arterial thromboembolism or gallbladder disease ; and
- File a claim form no later than April 9, 2027, at 11:59 p.m. (Eastern Time).
I still have a question. Who should I contact?
For answers to common questions about class actions in Canada, such as timelines, eligibility, and settlement information, please visit our Class Action Lawsuit FAQ page.
If you have any additional questions, you can contact us by email at [email protected] or call us toll-free at 1.877.735.3842.